[HTML][HTML] Secukinumab loss of efficacy is perfectly counteracted by the introduction of combination therapy (rescue therapy): data from a multicenter real-life study in a …

G Damiani, G Odorici, A Pacifico, A Morrone… - Pharmaceuticals, 2022 - mdpi.com
Since psoriasis (PsO) is a chronic inflammatory disease, patients may experience a drug
failure also with very effective drugs (ie, secukinumab) and, consequently, dermatologists …

Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life Study in a …

G Damiani, G Odorici, A Pacifico, A Morrone… - …, 2022 - search.proquest.com
Since psoriasis (PsO) is a chronic inflammatory disease, patients may experience a drug
failure also with very effective drugs (ie, secukinumab) and, consequently, dermatologists …

[HTML][HTML] Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life …

G Damiani, G Odorici, A Pacifico, A Morrone… - …, 2022 - ncbi.nlm.nih.gov
Since psoriasis (PsO) is a chronic inflammatory disease, patients may experience a drug
failure also with very effective drugs (ie, secukinumab) and, consequently, dermatologists …

[PDF][PDF] Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life Study …

G Damiani, G Odorici, A Pacifico, A Morrone… - …, 2022 - researchgate.net
Since psoriasis (PsO) is a chronic inflammatory disease, patients may experience a drug
failure also with very effective drugs (ie, secukinumab) and, consequently, dermatologists …

Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life Study in a …

G Damiani, G Odorici, A Pacifico… - Pharmaceuticals …, 2022 - search.ebscohost.com
Since psoriasis (PsO) is a chronic inflammatory disease, patients may experience a drug
failure also with very effective drugs (ie, secukinumab) and, consequently, dermatologists …

Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life Study in a …

G Damiani, G Odorici, A Pacifico… - Pharmaceuticals …, 2022 - pubmed.ncbi.nlm.nih.gov
Since psoriasis (PsO) is a chronic inflammatory disease, patients may experience a drug
failure also with very effective drugs (ie, secukinumab) and, consequently, dermatologists …

Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life Study in a …

G Damiani, G Odorici, A Pacifico, A Morrone… - Pharmaceuticals …, 2022 - europepmc.org
Since psoriasis (PsO) is a chronic inflammatory disease, patients may experience a drug
failure also with very effective drugs (ie, secukinumab) and, consequently, dermatologists …

[PDF][PDF] Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life Study …

G Damiani, G Odorici, A Pacifico, A Morrone… - …, 2022 - academia.edu
Since psoriasis (PsO) is a chronic inflammatory disease, patients may experience a drug
failure also with very effective drugs (ie, secukinumab) and, consequently, dermatologists …

Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life Study in a …

G Damiani, G Odorici, A Pacifico, A Morrone… - …, 2022 - air.unimi.it
Since psoriasis (PsO) is a chronic inflammatory disease, patients may experience a drug
failure also with very effective drugs (ie, secukinumab) and, consequently, dermatologists …

Secukinumab Loss of Efficacy Is Perfectly Counteracted by the Introduction of Combination Therapy (Rescue Therapy): Data from a Multicenter Real-Life Study in a …

G Damiani, G Odorici, A Pacifico, A Morrone… - Pharmaceuticals …, 2022 - europepmc.org
Since psoriasis (PsO) is a chronic inflammatory disease, patients may experience a drug
failure also with very effective drugs (ie, secukinumab) and, consequently, dermatologists …